Skip to content
BLACK BOOK
manufacturer✓ Verified☎ Contact on file

Contineum Therapeutics, Inc.

Pharmaceutical Preparations · San Diego, CA, United States

  1. PrincipalsCarmine N. StengoneCEO and PresidentDaniel S. LorrainChief Scientific OfficerPeter T SloverChief Financial Officerand 2 more
  2. CompanyContineum Therapeutics, Inc.San Diego, CA, United States
  3. Phone line+1 (858) 333-5280General business
Request a quote

Contineum Therapeutics, Inc. is an SEC-registered Nasdaq-listed company (ticker CTNM) classified under SIC 2834: Pharmaceutical Preparations.

Capabilities

✓ Pharmaceutical manufacturing
Evidence for each capability
  • Pharmaceutical manufacturing. SIC 2834 — Pharmaceutical Preparations — SEC EDGAR company submissions

People 5

Chief executive

Carmine N. StengoneCEO and President

Finance

Peter T SloverChief Financial Officer

Legal

John Stephen HealyGeneral Counsel and Corp Sec
Everyone else on file (2)
Daniel S. LorrainChief Scientific Officer
Tim WatkinsCMO & Head of Development

Supplier profile

Production
Yes

Source timeline

  1. Record created from SEC EDGAR company submissions

    SEC EDGAR company submissions ↗
  2. Carmine N. Stengone — CEO and President

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  3. Daniel S. Lorrain — Chief Scientific Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  4. Peter T Slover — Chief Financial Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  5. Tim Watkins — CMO & Head of Development

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗

Similar makers